ALG3-CDG patients display developmental and intellectual disabilities, muscular hypotonia, cerebral malformations, neurological features such as epileptic seizures, cardiac defects, facial and body dysmorphism, and metabolic dysfunction including refractory hypoglycemia (42, 44). The gene discussed is ALG3; the disease is Intellectual disability.